TRUSELTIQ

Peak

infigratinib phosphate

NDAORALCAPSULEPriority Review
Approved
May 2021
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Dec 11, 2034
106 months away
Patent Expiry
Dec 11, 2034
Exclusivity Expiry
May 28, 2028

Patent Records (4)

Patent #ExpiryTypeUse Code
9067896
Aug 6, 2028
Substance
8552002
Aug 25, 2029
SubstanceProduct
10278969
Dec 11, 2034
Product
11160804
Dec 11, 2034
Product